Clinical Trials Browser

Interventional × anlotinib × Other solid neoplasm × Clear all

NCT06761417 2025-01-08

A Prospective, Single-arm Clinical Study of Liposomal Mitoxantrone Combination Regimen in the Treatment of Relapsed and Refractory Solid Tumors in Children, Adolescents and Young Adults

Phase 2 Not yet recruiting

Other solid neoplasm

Solid Tumors

NCT06739395 2024-12-18

Precision Medicine Trial Based on Molecular Matching Therapy for Patients With Standard Treatment Exhaustion

Phase 2 Recruiting

Other solid neoplasm

Solid Tumor

NCT04291248 2020-03-02

A Study of Anlotinib Combined With AK105 Injection in Subjects With Microsatellite Instability-High (MSI-H) or Mismatch Repair Deficient (dMMR) Advanced Solid Tumor

Phase 2 Unknown

Other solid neoplasm

MSI-H or dMMR Advanced Solid Tumors

NCT03897283 2019-10-30

Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid Tumors

Phase 1 Unknown

Other solid neoplasm

Advanced Solid Tumors

NCT03975036 2019-06-05

Clinical Study on the Second-line and Above Treatment of Advanced Solid Tumor With Anlotinib Combined With Pd-1 Antibody

Phase 2/3 Unknown

Other solid neoplasm

Advanced Solid Tumor

NCT02622932 2019-04-30

Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer Patients

Phase 1 Completed

Other solid neoplasm

Advanced Solid Tumors

NCT03929965 2019-04-29

Anlotinib in Advanced Solid Tumors With FGFR Alteration

Phase NA Unknown

Other solid neoplasm

Advanced Solid Tumor